More specifically, the expression of GSDMD (an executor of pyroptosis) is significantly reduced in gastric cancer and promotes tumor proliferation [9], while in non-small cell lung cancer, GSDMD is highly expressed with a poorer prognosis. Here, GSDMD is linked to neoplasm.